NEUBASE THERAPEUTICS INC (NBSE)
Institutional ownership reported to the SEC as of Q2 2024, across 12 quarters.
1
Reporting holders
$5.0K
Reported value
0.0%
Held as options
-15
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Baader Bank Aktiengesellschaft | $5.0K | 16,089 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2024 | 1 | $5.0K | 16,089 | 1 | 0 | 0 | 0.0% |
| Q1 2024 | 16 | $137.1K | 305,030 | 1 | 2 | 1 | 0.0% |
| Q4 2023 | 19 | $298.2K | 402,969 | 3 | 3 | 3 | 0.0% |
| Q3 2023 | 18 | $260.4K | 299,371 | 1 | 3 | 3 | 0.0% |
| Q2 2023 | 22 | $866.1K | 463,214 | 22 | 0 | 0 | 0.0% |
| Q2 2022 | 1 | $14.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2022 | 1 | $41.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $13.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q3 2021 | 2 | $58.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $112.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 2 | $71.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q4 2020 | 1 | $17.0K | 0 | 1 | 0 | 0 | 100.0% |